240 likes | 249 Views
Analysis of pediatric ERF trends based on age, gender, ethnicity, diagnoses, and treatments in the UK, as reported in the 9th Annual UK Renal Registry (2006).
E N D
Fig 13.1 ERF patients below 15 years of age, by year of data collection UK Renal Registry 9th Annual Report 2006
Fig 13.2 ERF population in 4 year age bands UK Renal Registry 9th Annual Report 2006
Fig 13.3 Gender distribution of the ERF population, according to age UK Renal Registry 9th Annual Report 2006
Fig 13.4 Age distribution of the White and Ethnic minority patients UK Renal Registry 9th Annual Report 2006
Figure 5. Gender distribution and ethnicity in the paediatric population UK Renal Registry 9th Annual Report 2006
Fig 13.6 Prevalence of ERF according to gender UK Renal Registry 9th Annual Report 2006
Fig 13.7 Prevalence of ERF according to ethnicity. UK Renal Registry 9th Annual Report 2006
Fig 13.8 Take on rate of children with ERF according to gender UK Renal Registry 9th Annual Report 2006
Fig 13.9 Take on rate of children with ERF according to ethnicity UK Renal Registry 9th Annual Report 2006
Figure 10. Gender distribution of the ERF population, according to diagnostic group UK Renal Registry 9th Annual Report 2006
Fig 13.11 Percentage of inherited disease, according to ethnicity UK Renal Registry 9th Annual Report 2006
Fig 13.12(a) Percentage of patients with renal dysplasia, obstructive uropathy, glomerular diseases and reflux nephropathy presenting in each age band UK Renal Registry 9th Annual Report 2006
Fig 13.12(b) Percentage of patients presenting in each age band with renal dysplasia UK Renal Registry 9th Annual Report 2006
Fig 13.13(a) Percentage of patients with tubulo-interstitial diseases, metabolic diseases, congenital nephrosis and polycystic disease presenting in each age band UK Renal Registry 9th Annual Report 2006
Fig 13.13(b) Percentage of patients presenting in each age band with tubulo-interstitial or metabolic disease, congenital nephrosis or polycystic kidneys as the cause UK Renal Registry 9th Annual Report 2006
Fig 14.14(a) Percentage of patients with renovascular diseases, malignant diseases, drug nephrotoxicity and uncertain aetiology presenting in each age band UK Renal Registry 9th Annual Report 2006
Fig 14.14(b) Percentage of patients presenting in each age band with renovascular or malignant disease, drug nephrotocicity as the cause or uncertain aetiology UK Renal Registry 9th Annual Report 2006
Figure 15. Distribution of modalities in paediatric patients on 1st April 2005 UK Renal Registry 9th Annual Report 2006
Fig 13.16 Percentage of patients with renal allografts whose graft came from a living rather than cadaveric donor UK Renal Registry 9th Annual Report 2006
Fig 13.17 Distribution of treatments according to ethnicity UK Renal Registry 9th Annual Report 2006
Fig 13.18 ERF treatment modality changes from 2004 to 2005 UK Renal Registry 9th Annual Report 2006
Figure 13.19 Distribution of treatments in those unchanged from 2004 to 2005 UK Renal Registry 9th Annual Report 2006
Fig 13.20 ERF treatment changes from 2004 to 2005 UK Renal Registry 9th Annual Report 2006
Fig 13.21 ERF treatment in April 2005 for those starting after April 2004 UK Renal Registry 9th Annual Report 2006